Audrey Roberson
Family · Atlanta, GANPI 1811495385
Payments from drug & device makers
Across 139 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$299
- Novo Nordisk$285
- AbbVie$200
- Vanda Pharmaceuticals Inc.$176
- AstraZeneca$171
- GSK$167
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,522100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 15 | $299 |
| Novo Nordisk | 22 | $285 |
| AbbVie(2 entities) | 11 | $200 |
| Vanda Pharmaceuticals Inc. | 9 | $176 |
| AstraZeneca | 4 | $171 |
| GSK | 9 | $167 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $153 |
| Xeris Pharmaceuticals, Inc. | 7 | $134 |
| Bayer | 6 | $130 |
| Amgen | 7 | $104 |
| Esperion Therapeutics, Inc. | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Boehringer Ingelheim | 4 | $74 |
| Merck | 5 | $74 |
| Mylan Specialty L.p. | 4 | $68 |
| Eisai Inc. | 4 | $67 |
| Sanofi-aventis U.S. LLC | 4 | $65 |
| Shield Therapeutics Inc | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Sunovion Pharmaceuticals Inc. | 2 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Novartis | 1 | $20 |
| Genentech USA, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$125
How this compares
$2,522 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $816 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 23 | $404 |
| Fluconazole | 26 | $162 |
Paid to pharmacies, not to this prescriber.
Other family in Atlanta
- Stacey TatroeAtlanta$38K
- Brandy HughesAtlanta$29K
- Cecile MartinAtlanta$23K
- Terri CowanAtlanta$21K
- Brandi Pinckney-GreeneAtlanta$18K
- Michelle SarievAtlanta$18K
- Christopher VreelandAtlanta$17K
- Angelica MillerAtlanta$15K
- Andrea Jefferson SaboorAtlanta$14K
- Allie McAllisterMarietta$299K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.